Express Pharma

DRL launches esomeprazole magnesium delayed-release capsules

1

The 20 mg and 40 mg capsules are available in bottle count size of 30

Dr Reddy’s Laboratories (DRL) has launched esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg, a therapeutic equivalent generic version of Nexium  (esomeprazole magnesium) delayed-release capsules in the US market on September 25, 2015, following the approval by the United States Food & Drug Administration (US FDA).

The Nexium (esomeprazole magnesium) delayed-release capsules brand and generic had US sales of approximately $5.2 billion MAT for the most recent twelve months ending in July 2015 according to IMS Health.

DRL’s esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg are available in bottle count size of 30.

Comments are closed.